Genomics · Human Whole Genome

The whole human genome, read and interpreted.

Human whole genome sequencing reads all three billion base pairs of a person's DNA, covering coding and non-coding regions alike. We sequence germline genomes at 30× or higher, and tumour genomes deeper, then call SNVs, indels, copy-number and structural variants with established pipelines for research, cohort and population studies.

30×+
germline coverage
SNV + indel
small variants
CNV + SV
structural variants
Cohort-ready
joint calling

Human WGS at Nucleome Informatics

Research-grade human genome sequencing, from DNA QC to annotated variants.

  • Blood, saliva, tissue or FFPE DNA with quality assessment
  • PCR-free or PCR-based library preparation according to input
  • Paired-end short-read sequencing at 30× germline or higher for tumour samples
  • Alignment to GRCh38 with standard QC metrics
  • Small-variant, copy-number and structural-variant calling
  • Variant annotation, population frequencies and cohort joint genotyping

Why whole genome

  • Complete: covers exons, introns, regulatory regions and intergenic DNA.
  • Uniform: more even coverage than capture-based exome sequencing.
  • Versatile: one dataset supports small variants, CNVs, SVs and population analysis.

From first principles to expert-level analysis

Three levels, from what a genome is to how variant calling choices matter.

What human genome sequencing measures.

LEVEL 1

The genome

About three billion DNA letters in 23 chromosome pairs.

LEVEL 1

Variants

Differences from the reference, from single letters to large rearrangements.

LEVEL 1

Coverage

How many reads overlap each position; 30× is standard for germline genomes.

LEVEL 1

Uses

Disease research, population genetics, pharmacogenomics and cancer studies.

Design choices that decide data quality.

LEVEL 2

Depth

30× for germline; tumours are sequenced deeper with matched normal samples.

LEVEL 2

PCR-free libraries

Reduce bias and improve indel accuracy when DNA input allows.

LEVEL 2

Sample type

Blood and saliva give high-quality DNA; FFPE needs extra care.

LEVEL 2

Cohort design

Joint calling across samples improves consistency.

Analysis decisions that change conclusions.

LEVEL 3

Caller choice

GATK and deep-learning callers have different strengths.

LEVEL 3

Difficult regions

Segmental duplications and repeats need careful interpretation or long reads.

LEVEL 3

Structural variants

Short reads detect many SVs but miss some; long reads complete the picture.

LEVEL 3

Interpretation

Variant classification frameworks guide clinical relevance in research settings.

How it works, in two figures

How whole genome compares with exome sequencing, and the path from DNA to variants.

Figure 1 Exome versus whole genome. schematic
Exome sequencingWhole genome sequencing~2% of the genome capturedUneven capture coverageLimited CNV and SV detectionWhole genome sequencedMore uniform coverageSNVs, indels, CNVs and SVs
Figure 1 | Whole genome sequencing covers coding and non-coding DNA with more uniform coverage. (Illustrative schematic, not sample data.)
Figure 2 Workflow. schematic
STEP 1DNA QCSTEP 2Library prepSTEP 3SequencingSTEP 4Alignment (GRCh38)STEP 5Variant callingSTEP 6AnnotationSTEP 7Report
Figure 2 | From DNA to annotated small and structural variants. (Illustrative schematic, not sample data.)

Built for the questions you are asking

Proven tools and transparent QC at each step.

Sample QC

DNA quantity and integrity checks before library preparation.

Library options

PCR-free and PCR-based libraries matched to input.

Alignment

BWA-based mapping to GRCh38 with duplicate marking.

Variant calling

GATK best practices and deep-learning callers for small variants.

CNV & SV calling

Copy-number and structural variants from read depth and split reads.

Annotation

Gene effects, population frequencies and variant databases.

What this service does and does not cover

Scope note. Short-read genomes resolve most of the genome but under-perform in long repeats and segmental duplications, where our long-read WGS services help. This service is for research; clinical diagnostic testing is offered through our Genetic Testing services.

Service highlights

What you can expect when you work with us.

One team, end to end

Sample QC, library preparation, sequencing and bioinformatics in one place, so nothing is lost in hand-offs.

Study design support

We help you choose depth, replicates and controls before you spend on sequencing.

Transparent QC

Every sample comes with clear quality metrics, so you know what the data can support.

Publication-ready output

Figures, tables and a methods description you can use directly in your manuscript.

Long-read option

Difficult regions can be resolved with PacBio HiFi or Oxford Nanopore sequencing.

Population scale

Joint calling and consistent processing for large cohorts.

Frequently asked, in plain language

Short answers to the questions researchers ask us most often.

basicWhat coverage do I need?
30× is standard for germline genomes; tumour genomes are usually sequenced deeper with a matched normal.
basicWhat samples can I send?
Blood, saliva, tissue or FFPE DNA; requirements depend on the library type.
basicWhat variants are reported?
SNVs, small indels, copy-number variants and structural variants.
intermediateExome or genome?
The exome focuses on coding regions; the genome covers everything with more uniform coverage and better CNV/SV detection.
intermediateCan you sequence a cohort?
Yes. Large studies are processed consistently with joint variant calling.
advancedIs this a clinical test?
No. For clinical testing see our WGS and rare disease services under Genetic Testing.

Key literature & resources

Foundational papers behind the methods and tools named on this page.

  1. Li H, Durbin R. Fast and accurate short read alignment with Burrows–Wheeler transform. Bioinformatics. 2009;25(14):1754–1760.
  2. McKenna A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Research. 2010;20(9):1297–1303.
  3. Poplin R, et al. A universal SNP and small-indel variant caller using deep neural networks. Nature Biotechnology. 2018;36(10):983–987.
  4. The 1000 Genomes Project Consortium. A global reference for human genetic variation. Nature. 2015;526(7571):68–74.